Doherty JA, Peres LC, Wang C, Way GP, Greene CS, Schildkraut JM. Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes. Curr Epidemiol Rep. 2017;4(3):211–20.

PubMed  PubMed Central  Article  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

PubMed  Article  Google Scholar 

Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10(4):211–24.

PubMed  PubMed Central  Article  Google Scholar 

Hess JR, Greenberg NA. The role of nucleotides in the immune and gastrointestinal systems: potential clinical applications. Nutr Clin Pract. 2012;27(2):281–94.

PubMed  Article  Google Scholar 

De Vitto H, Arachchige DB, Richardson BC, French JB. The intersection of purine and mitochondrial metabolism in cancer. Cells-Basel. 2021;10(10):2603.

Article  CAS  Google Scholar 

Camici M, Garcia-Gil M, Pesi R, Allegrini S, Tozzi MG. Purine-metabolising enzymes and apoptosis in cancer. Cancers (Basel). 2019;11(9):1354.

Article  CAS  Google Scholar 

Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res. 1989;181(2):305–16.

PubMed  Article  CAS  Google Scholar 

Reilly NM, Novara L, Di Nicolantonio F, Bardelli A. Exploiting DNA repair defects in colorectal cancer. Mol Oncol. 2019;13(4):681–700.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Karran P. Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull. 2006;79–80:153–70.

PubMed  Article  CAS  Google Scholar 

D’Almeida SM, Kauffenstein G, Roy C, Basset L, Papargyris L, Henrion D, Catros V, Ifrah N, Descamps P, Croue A, et al. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27. Oncoimmunology. 2016;5(7):e1178025.

Coulthard S, Hogarth L. The thiopurines: an update. Invest New Drugs. 2005;23(6):523–32.

PubMed  Article  CAS  Google Scholar 

Anderson VR, Perry CM. Fludarabine: a review of its use in non-Hodgkin’s lymphoma. Drugs. 2007;67(11):1633–55.

Campos-Contreras A, Diaz-Munoz M, Vazquez-Cuevas FG. Purinergic signaling in the hallmarks of cancer. Cells-Basel. 2020;9(7):1612.

Article  CAS  Google Scholar 

Li L, Wang L, Li J, Fan Z, Yang L, Zhang Z, Zhang C, Yue D, Qin G, Zhang T, et al. Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer. Cancer Res. 2018;78(7):1779–91.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Montalban DBI, Penski C, Schlahsa L, Stein RG, Diessner J, Wockel A, Dietl J, Lutz MB, Mittelbronn M, Wischhusen J, et al. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape. J Immunother Cancer. 2016;4:49.

Article  Google Scholar 

Turcotte M, Spring K, Pommey S, Chouinard G, Cousineau I, George J, Chen GM, Gendoo DM, Haibe-Kains B, Karn T, et al. CD73 is associated with poor prognosis in high-grade serous ovarian cancer. Cancer Res. 2015;75(21):4494–503.

PubMed  Article  CAS  Google Scholar 

Oh HK, Sin JI, Choi J, Park SH, Lee TS, Choi YS. Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration. J Gynecol Oncol. 2012;23(4):274–81.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Gines S, Marino M, Mallol J, Canela EI, Morimoto C, Callebaut C, Hovanessian A, Casado V, Lluis C, Franco R. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem J. 2002;361(Pt 2):203–9.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Urunsak IF, Gulec UK, Paydas S, Seydaoglu G, Guzel AB, Vardar MA. Adenosine deaminase activity in patients with ovarian neoplasms. Arch Gynecol Obstet. 2012;286(1):155–9.

PubMed  Article  CAS  Google Scholar 

Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279–90.

PubMed  Article  CAS  Google Scholar 

Zhang M, Fritsche J, Roszik J, Williams LJ, Peng X, Chiu Y, Tsou CC, Hoffgaard F, Goldfinger V, Schoor O, et al. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat Commun. 2018;9(1):3919.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol. 1995;15(10):5376–88.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Barraud P, Banerjee S, Mohamed WI, Jantsch MF, Allain FH. A bimodular nuclear localization signal assembled via an extended double-stranded RNA-binding domain acts as an RNA-sensing signal for transportin 1. Proc Natl Acad Sci U S A. 2014;111(18):E1852–61.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tan TY, Sedmik J, Fitzgerald MP, Halevy RS, Keegan LP, Helbig I, Basel-Salmon L, Cohen L, Straussberg R, Chung WK, et al. Bi-allelic ADARB1 variants associated with microcephaly, intellectual disability, and seizures. Am J Hum Genet. 2020;106(4):467–83.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Zhang XY, Zhou LL, Jiao Y, Li YQ, Guan YN, Zhao YC, Zheng LW. Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer. Medicine (Baltimore). 2021;100(1):e24134.

Article  CAS  Google Scholar 

Huang M, Qin X, Wang Y, Mao F. Identification of AK4 as a novel therapeutic target for serous ovarian cancer. Oncol Lett. 2020;20(6):346.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tan H, Wu C, Huang B, Jin L, Jiang X. MiR-3666 serves as a tumor suppressor in ovarian carcinoma by down-regulating AK4 via targeting STAT3. Cancer Biomark. 2021;30(4):355–63.

PubMed  Article  CAS  Google Scholar 

Look KY, Sutton GP, Natsumeda Y, Eble JN, Stehman FB, Ehrlich CE, Olah E, Prajda N, Bosze P, Eckhardt S, et al. Inhibition by tiazofurin of inosine 5’-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas. Gynecol Oncol. 1992;47(1):66–70.

Tian Y, Zhang J, Chen L, Zhang X. The expression and prognostic role of IMPDH2 in ovarian cancer. Ann Diagn Pathol. 2020;46:151511.

PubMed  Article  Google Scholar 

Hunakova L, Bies J, Sedlak J, Duraj J, Jakubikova J, Takacsova X, Novotny L, Chorvath B. Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside. Neoplasma. 2000;47(5):274–9.

PubMed  CAS  Google Scholar 

Duong-Ly KC, Kuo YM, Johnson MC, Cote JM, Kollman JM, Soboloff J, Rall GF, Andrews AJ, Peterson JR. T cell activation triggers reversible inosine-5’-monophosphate dehydrogenase assembly. J Cell Sci. 2018;131(17):jcs223289.

Giuliani P, Zuccarini M, Buccella S, Pena-Altamira LE, Polazzi E, Virgili M, Monti B, Poli A, Rathbone MP, Di Iorio P, et al. Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells. J Neurochem. 2017;141(2):208–21.

PubMed  Article  CAS  Google Scholar 

Ofinran O, Bose U, Hay D, Abdul S, Tufatelli C, Khan R. Selection of suitable reference genes for gene expression studies in normal human ovarian tissues, borderline ovarian tumours and ovarian cancer. Mol Med Rep. 2016;14(6):5725–31.

PubMed  Article  CAS  Google Scholar 

Wang L, Wang Y, Han N, Wang X, Ruan M. HPRT promotes proliferation and metastasis in head and neck squamous cell carcinoma through direct interaction with STAT3. Exp Cell Res. 2021;399(1):112424.

PubMed  Article  CAS  Google Scholar 

Keough DT, Hockova D, Holy A, Naesens LM, Skinner-Adams TS, Jersey J, Guddat LW. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. J Med Chem. 2009;52(14):4391–9.

PubMed  Article  CAS  Google Scholar 

Scanlon KJ, Kashani-Sabet M. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. Proc Natl Acad Sci U S A. 1988;85(3):650–3.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Marverti G, Ligabue A, Paglietti G, Corona P, Piras S, Vitale G, Guerrieri D, Luciani R, Costi MP, Frassineti C, et al. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells. Eur J Pharmacol. 2009;615(1–3):17–26.

PubMed  Article  CAS  Google Scholar 

Trent JM, Buick RN, Olson S, Horns RJ, Schimke RT. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J Clin Oncol. 1984;2(1):8–15.

PubMed  Article  CAS  Google Scholar 

Chen J, Li L. Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma. Anal Cell Pathol (Amst). 2019;2019:1438628.

Google Scholar 

Viel A, Dall’Agnese L, Simone F, Canzonieri V, Capozzi E, Visentin MC, Valle R, Boiocchi M. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer. 1997;75(8):1105–10.

Gong JM, Shen Y, Shan WW, He YX. The association between MTHFR polymorphism and cervical cancer. Sci Rep. 2018;8(1):7244.

PubMed  PubMed Central  Article  CAS